These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27842795)

  • 41. Interpretation of urine drug testing in pain patients.
    Pesce A; West C; Egan City K; Strickland J
    Pain Med; 2012 Jul; 13(7):868-85. PubMed ID: 22494459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients with pain and addiction: what's a doctor to do?
    Seppala M
    Minn Med; 2006 Sep; 89(9):41-3. PubMed ID: 17024924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reducing the pain in pain management.
    Stefanacci RG; Riddle A
    Geriatr Nurs; 2017; 38(1):74-77. PubMed ID: 28104288
    [No Abstract]   [Full Text] [Related]  

  • 44. Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abuse.
    Paulozzi LJ; Zhou C; Jones CM; Xu L; Florence CS
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):545-52. PubMed ID: 26861165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Family doctor's role in pain management.
    Glaser T
    Fam Pract Manag; 2001; 8(10):12. PubMed ID: 11757231
    [No Abstract]   [Full Text] [Related]  

  • 46. Reflecting on pain control.
    Stephen JM; Weiner SG
    Acad Emerg Med; 2009 Dec; 16(12):1386-1387. PubMed ID: 19895630
    [No Abstract]   [Full Text] [Related]  

  • 47. Why is urine drug testing not used more often in practice?
    Bair MJ; Krebs EE
    Pain Pract; 2010; 10(6):493-6. PubMed ID: 21040440
    [No Abstract]   [Full Text] [Related]  

  • 48. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients.
    Adams LL; Gatchel RJ; Robinson RC; Polatin P; Gajraj N; Deschner M; Noe C
    J Pain Symptom Manage; 2004 May; 27(5):440-59. PubMed ID: 15120773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of chronic noncancer pain in the primary care setting.
    Nicholson B; Passik SD
    South Med J; 2007 Oct; 100(10):1028-36. PubMed ID: 17943050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concern about use of narcotics for pain in sickle cell anemia.
    Johnson NA
    Am Fam Physician; 1995 Jan; 51(1):47-8. PubMed ID: 7810478
    [No Abstract]   [Full Text] [Related]  

  • 51. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving use of narcotics for nonmalignant chronic pain: a lesson from Community Care of North Carolina.
    Bujold E; Huff J; Staton EW; Pace WD
    J Opioid Manag; 2012; 8(6):363-7. PubMed ID: 23264314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The opiate dilemma.
    Jeffrey PL; Lenz K
    J Manag Care Spec Pharm; 2014 May; 20(5):437-8. PubMed ID: 24761814
    [No Abstract]   [Full Text] [Related]  

  • 54. How Can Routine Clinical Laboratories Keep Up with the Opioid Crisis?
    Snozek CLH; Baskin LB; Boyd JM; Kelly BN; Krasowski MD; Sadrzadeh SMH; Tacker DH
    Clin Chem; 2021 Jan; 67(2):338-344. PubMed ID: 33523216
    [No Abstract]   [Full Text] [Related]  

  • 55. The Opioid Epidemic.
    Stempniak M
    Hosp Health Netw; 2016 Mar; 90(3):22-4, 26-9. PubMed ID: 27180399
    [No Abstract]   [Full Text] [Related]  

  • 56. Opioids for intractable pain: the good, the bad and the ugly.
    Gallagher RM
    Pain Med; 2005; 6(2):103-4. PubMed ID: 15773872
    [No Abstract]   [Full Text] [Related]  

  • 57. Improving opioid prescribing: the New York City recommendations.
    Juurlink DN; Dhalla IA; Nelson LS
    JAMA; 2013 Mar; 309(9):879-80. PubMed ID: 23462783
    [No Abstract]   [Full Text] [Related]  

  • 58. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment.
    Volkow ND; McLellan TA
    JAMA; 2011 Apr; 305(13):1346-7. PubMed ID: 21467287
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug testing and adherence monitoring in pain management: Oral fluid testing.
    Moore C
    J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Importance of urine drug testing in the treatment of chronic noncancer pain: implications of recent medicare policy changes in kentucky.
    Gilbert JW; Wheeler GR; Mick GE; Storey BB; Herder SL; Richardson GB; Watts E; Gyarteng-Dakwa K; Marino BS; Kenney CM; Siddiqi M; Broughton PG
    Pain Physician; 2010; 13(2):167-86. PubMed ID: 20309383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.